141 related articles for article (PubMed ID: 11557442)
1. Head and neck paragangliomas: physiology and biochemistry.
McCaffrey TV; Myssiorek D; Marrinan M
Otolaryngol Clin North Am; 2001 Oct; 34(5):837-44, v. PubMed ID: 11557442
[TBL] [Abstract][Full Text] [Related]
2. Basic fibroblast growth factor and fibroblastic growth factor receptor-1 may contribute to head and neck paraganglioma development by an autocrine or paracrine mechanism.
Douwes Dekker PB; Kuipers-Dijkshoorn NJ; Baelde HJ; van der Mey AG; Hogendoorn PC; Cornelisse CJ
Hum Pathol; 2007 Jan; 38(1):79-85. PubMed ID: 16949906
[TBL] [Abstract][Full Text] [Related]
3. Secreting vagal paraganglioma.
Groblewski JC; Thekdi A; Carrau RL
Am J Otolaryngol; 2004; 25(4):295-300. PubMed ID: 15239042
[TBL] [Abstract][Full Text] [Related]
4. What we call them: the nomenclature of head and neck paragangliomas.
Martin TP
Clin Otolaryngol; 2006 Jun; 31(3):185-6. PubMed ID: 16759236
[No Abstract] [Full Text] [Related]
5. Which paragangliomas of the head and neck have a higher rate of malignancy?
Rinaldo A; Myssiorek D; Devaney KO; Ferlito A
Oral Oncol; 2004 May; 40(5):458-60. PubMed ID: 15006616
[No Abstract] [Full Text] [Related]
6. Paragangliomas of the head and neck. Immunohistochemical analysis of 16 cases in comparison with neuro-endocrine carcinomas.
Martinez-Madrigal F; Bosq J; Micheau C; Nivet P; Luboinski B
Pathol Res Pract; 1991 Sep; 187(7):814-23. PubMed ID: 1754507
[TBL] [Abstract][Full Text] [Related]
7. Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib.
Verginelli F; Perconti S; Vespa S; Schiavi F; Prasad SC; Lanuti P; Cama A; Tramontana L; Esposito DL; Guarnieri S; Sheu A; Pantalone MR; Florio R; Morgano A; Rossi C; Bologna G; Marchisio M; D'Argenio A; Taschin E; Visone R; Opocher G; Veronese A; Paties CT; Rajasekhar VK; Söderberg-Nauclér C; Sanna M; Lotti LV; Mariani-Costantini R
Acta Neuropathol; 2018 May; 135(5):779-798. PubMed ID: 29305721
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and evaluation of head and neck paragangliomas. Clinical and biological manifestations].
Sánchez Marcos AI; Santos Gorjón P; Sánchez González F; Muñoz Herrera A
Acta Otorrinolaringol Esp; 2009 Feb; 60 Suppl 1():34-44. PubMed ID: 19245774
[TBL] [Abstract][Full Text] [Related]
9. Dopamine excess in patients with head and neck paragangliomas.
Van Der Horst-Schrivers AN; Osinga TE; Kema IP; Van Der Laan BF; Dullaart RP
Anticancer Res; 2010 Dec; 30(12):5153-8. PubMed ID: 21187504
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of somatostatin receptor imaging in patients with suspected head and neck paragangliomas.
Schmidt M; Fischer E; Dietlein M; Michel O; Weber K; Moka D; Stennert E; Schicha H
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1571-80. PubMed ID: 12458390
[TBL] [Abstract][Full Text] [Related]
11. Head and Neck Paragangliomas: An Update on Evaluation and Management.
Moore MG; Netterville JL; Mendenhall WM; Isaacson B; Nussenbaum B
Otolaryngol Head Neck Surg; 2016 Apr; 154(4):597-605. PubMed ID: 26861230
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck.
Duet M; Sauvaget E; Pételle B; Rizzo N; Guichard JP; Wassef M; Le Cloirec J; Herman P; Tran Ba Huy P
J Nucl Med; 2003 Nov; 44(11):1767-74. PubMed ID: 14602858
[TBL] [Abstract][Full Text] [Related]
13. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Paragangliomas.
Williams MD; Tischler AS
Head Neck Pathol; 2017 Mar; 11(1):88-95. PubMed ID: 28247224
[TBL] [Abstract][Full Text] [Related]
14. Paragangliomas of the Head and Neck.
Woolen S; Gemmete JJ
Neuroimaging Clin N Am; 2016 May; 26(2):259-78. PubMed ID: 27154608
[TBL] [Abstract][Full Text] [Related]
15. [Head and neck paragangliomas. Embryological origin and anatomical characteristics: topographic distribution and vascularization pattern].
Carretero González J; Blanco Pérez P; Vázquez Osorio MT; Benito González F; Sañudo Tejedo JR
Acta Otorrinolaringol Esp; 2009 Feb; 60 Suppl 1():9-17. PubMed ID: 19245770
[TBL] [Abstract][Full Text] [Related]
16. Multiple paragangliomas of head and neck associated with hepatic paraganglioma: a case report.
Xiao Z; She D; Cao D
BMC Med Imaging; 2015 Sep; 15():38. PubMed ID: 26407551
[TBL] [Abstract][Full Text] [Related]
17. A functioning catecholamine-secreting vagal body tumor. A case report and review of the literature.
Tannir NM; Cortas N; Allam C
Cancer; 1983 Sep; 52(5):932-5. PubMed ID: 6347360
[TBL] [Abstract][Full Text] [Related]
18. Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing.
Johnson TL; Zarbo RJ; Lloyd RV; Crissman JD
Mod Pathol; 1988 May; 1(3):216-23. PubMed ID: 2467285
[TBL] [Abstract][Full Text] [Related]
19. [Multiple and familial paragangliomas of the head and neck--review of literature and report of two cases].
Szyfter W; Wierzbicka M; Gawecki W
Otolaryngol Pol; 2008; 62(5):530-5. PubMed ID: 19004251
[TBL] [Abstract][Full Text] [Related]
20. Laryngeal paraganglioma in a patient with multiple head and neck paragangliomas.
Rubin AD; Cheng SS; Bradford CR
Otolaryngol Head Neck Surg; 2005 Mar; 132(3):520-2. PubMed ID: 15746877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
